SCOPUS 정보 검색 플랫폼

Annals of Pharmacotherapy

Volumn 34, Issue 12, 2000, Pages 1402-1405

Seizures associated with therapeutic doses of venlafaxine and trimipramine

(4) Schlienger, Raymond G a,b Klink, Markus H c Eggenberger, Christoph c Drewe, Jürgen a,b

a UNIVERSITY HOSPITAL BASEL (Switzerland)

b UNIVERSITY OF BASEL (Switzerland)

c University Hospital Bruderholz (Switzerland)

Author keywords

Cytochrome P450; Drug interaction; Seizures; Trimipramine; Venlafaxine

Indexed keywords

CYTOCHROME P450 2D6; TRIMIPRAMINE; VENLAFAXINE;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW UP; HUMAN; PRIORITY JOURNAL; SEIZURE;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CYCLOHEXANOLS; DRUG INTERACTIONS; FEMALE; HUMANS; MIDDLE AGED; SEIZURES; TRIMIPRAMINE;

EID: 0033634984 PISSN: 10600280 EISSN: None Source Type: Journal
DOI: 10.1345/aph.10050 Document Type: Article

Times cited : (14)

References (22)

1
- 0000352684
- Seizures after venlafaxine overdose: A case report
- (1995) J Toxicol Clin Toxicol , vol.33 , pp. 549-550
- Woo, O.F.¹ Vredenburg, M.² Freitas, P.³ Olson, K.R.⁴

2
- 0002993837
- Seizure associated with venlafaxine overdose
- (1996) J Toxicol Clin Toxicol , vol.34 , pp. 557
- Durback, L.F.¹ Scharman, E.J.²

3
- 0031019704
- Seizure resulting from a venlafaxine overdose
- (1997) Ann Pharmacother , vol.31 , pp. 178-180
- White, M.C.¹ Gailey, R.A.² Levin, G.M.³ Smith, T.⁴

4
- 0031910464
- Comment: Venlafaxine overdose and seizure
- (1998) Ann Pharmacother , vol.32 , pp. 135-136
- Leaf, E.V.¹

5
- 0031402748
- Seizure activity and enzyme elevations after venlafaxine overdose
- (1997) J Clin Psychopharmacol , vol.17 , pp. 490-491
- Zhalkovsky, B.¹ Walker, D.² Bourgeois, J.A.³

6
- 0031158857
- Comment: Seizure resulting from venlafaxine overdose
- (1997) Ann Pharmacother , vol.31 , pp. 790-791
- Durback, L.F.¹ Scharman, E.J.²

7
- 0029887138
- The safety and tolerability of venlafaxine hydrochloride: An analysis of the clinical trials database
- (1996) J Clin Psychopharmacol , vol.16 , pp. 54S-61S
- Rudolph, R.L.¹ Derivan, A.T.²

8
- 0033595492
- Seizure risk associated with psychotropic drugs: Clinical and pharmacokinetic considerations
- (1999) Neurology , vol.53 , pp. S68-S75
- Alldredge, B.K.¹

9
- 0027194342
- Seizures associated with antidepressants: A review
- (1993) J Clin Psychiatry , vol.54 , pp. 289-299
- Rosenstein, D.L.¹ Nelson, J.C.² Jacobs, S.C.³

10
- 0032804621
- Antidepressant drugs and seizure susceptibility: From in vitro data to clinical practice
- (1999) Epilepsia , vol.40 , pp. S48-S56
- Pisani, F.¹ Spina, E.² Oteri, G.³

11
- 0018901607
- Trimipramine: Twenty years' worldwide clinical experience
- (1980) J Clin Psychiatry , vol.41 , pp. 266-274
- Settle, E.C.¹ Ayd, F.J.²

12
- 0026022857
- Fatal seizures associated with trimipramine poisoning
- (1991) Forensic Sci Int , vol.49 , pp. 75-79
- Druid, H.¹ Holmgren, P.²

13
- 0016039793
- Clinical note: Seizures and EEG activation after trimipramine
- (1974) Epilepsia , vol.15 , pp. 131-135
- Legg, N.J.¹ Swash, M.²

14
- 0029876399
- Study on orthostatic dysregulation and the Schellong test in healthy young females
- (1996) ORL J Otorhinolaryngol Relat Spec , vol.58 , pp. 110-114
- Nozawa, I.¹ Hisamastu, K.² Imamura, S.³ Fujimori, I.⁴ Nakayama, H.⁵ Murakami, Y.⁶

15
- 0019799332
- A method for estimating the probability of adverse drug reactions
- (1981) Clin Pharmacol Ther , vol.30 , pp. 239-245
- Naranjo, C.A.¹ Busto, U.² Sellers, E.M.³ Sandor, P.⁴ Ruiz, I.⁵ Roberts, E.S.⁶

16
- 0027367373
- Metabolism of trimipramine in vitro by human CYP2D6 isozyme
- (1993) Res Commun Chem Pathol Pharmacol , vol.82 , pp. 111-120
- Bolaji, O.O.¹ Coutts, R.T.² Baker, G.B.³

17
- 0028280588
- Increased trimipramine plasma levels during fluvoxamine comedication
- (1994) Eur Neuropsychopharmacol , vol.4 , pp. 15-20
- Seifritz, E.¹ Holsboer-Trachsler, E.² Hemmeter, U.³ Eap, C.B.⁴ Baumann, P.⁵

18
- 0030045095
- Venlafaxine oxidation in vitro is catalysed by CYP2D6
- (1996) Br J Clin Pharmacol , vol.41 , pp. 149-156
- Otton, S.V.¹ Ball, S.E.² Cheung, S.W.³ Inaba, T.⁴ Rudolph, R.L.⁵ Sellers, E.M.⁶

19
- 0032587641
- Effect of CYP2D6*10 genotype on venlafaxine pharmacokinetics in healthy volunteers
- (1999) Br J Clin Pharmacol , vol.47 , pp. 450-453
- Fukuda, T.¹ Yamamoto, I.² Nishida, Y.³ Zhou, Q.⁴ Ohno, M.⁵ Takada, K.⁶

20
- 0030834105
- Venlafaxine: In vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism: Comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2
- (1997) Br J Clin Pharmacol , vol.43 , pp. 619-626
- Ball, S.E.¹ Ahern, D.² Scatina, J.³ Kao, J.⁴

21
- 0030659112
- Seizures and myoclonus associated with antidepressant treatment. Assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitors
- (1997) Acta Psychiatr Scand , vol.96 , pp. 379-384
- Spigset, O.¹ Hedenmalm, K.² Dahl, M.L.³ Wilholm, B.E.⁴ Dahlqvist, R.⁵

22
- 0027186219
- Genetically determined adverse drug reactions involving metabolism
- (1993) Drug Saf , vol.9 , pp. 60-77
- Lennard, M.S.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.